Avatar

Role of PCSK9 Inhibitors in Diabetes

By Stephen Kopecky 2 Videos
September 22, 2016
8 Comments
Login to view comments. Click here to Login

Featured Video

11:40
Novo Nordisk – GLP-1 RA Therapy

GLP-1 RA as a First Injectable for T2D: Is It as Effective as Basal …

Feat. C. Wierum, L. Coco

Featured Video

08:56
Janssen

The Importance of Returning to In-Person Care for Patients with Pulm…

Feat. R. Benza

Related Content

AUTOPLAY
28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Feat. R. Mason
21:27
Scripps Health

Lipids Update: Current Guidelines for Lipid Management

Feat. S. R. Mehta
45:45
Houston Methodist DeBakey Heart and Vascular Center

Directions of Cardiology in the Next Decade: 2022-2032

Feat. E. Braunwald
08:44
AHA 2022 Conference Coverage

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

Feat. N. Marston
19:48
ACC 2022 Conference Coverage

ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "…

Feat. R. Giugliano
22:14
Practical Ways to Achieve Targets in Diabetes Care

Role of Lipoprotein (a) in Coronary Disease: An Emerging Novel Target

Feat. S. Nissen
21:10
National Lipid Association

Plant-based Diets for Improving Lipids

Feat. K. Williams
25:02
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

How to Reduce Cholesterol and Triglycerides to Prevent CV Events

Feat. P. Taub
27:12
Norman Lepor

Update on Lipoprotein A: The Horrible Cholesterol

31:50
Nadir Ali

Do Statins Prevent or Cause Heart Disease? Should LDL Be Called &quo…

11:50
American Heart & Vascular Institute

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

Feat. M. Kittleson
39:44
The Texas Heart Institute

Lipid Lowering Therapies: Where Did We Start, Where We Are Now and W…

Feat. S. Virani
11:26
Houston Methodist DeBakey Heart and Vascular Center

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Feat. M. Miedema
11:10
Craig Beavers

PCSK9 Inhibitors: Pharmacology, Indications, Drug Interactions, Dosi…

67:29
Philips

Step Ahead - PAD & CLI State of the Art and the COVID 19 Era Imp…

Feat. C. Walker, C. Lesar, S. Madassery, T. Yates
25:54
13th Orange County Symposium for Cardiovascular Disease Prevention

SGLT2 inhibitors and GLP-1 agonists: Why Are They Important and Whic…

Feat. Y. Handelsman
25:21
University of California, Irvine (UCI) Health 14th Annual Orange County Symposium for Cardiovascular Disease Prevention

Lipoprotein(a): An Underrecognized Causal Risk Factor for Atheroscle…

Feat. N. Wong
18:42
Cardiometabolic Health Congress (CMHC)

ASCVD Risk Assessment and Prevention: Where Do We Stand Now?

Feat. S. Virani
35:46
37th Annual Advances in Heart Disease

Lipoprotein(a) and CVD: Do Elevated Lp(a) Levels Contribute to CVD R…

Feat. B. An Phan, P. Ganz
17:03
Nadir Ali

Why LDL Cholesterol Goes Up With Low Carb Diet and Is It Bad for Hea…